Sort
10,766 grants matching “checkpoint inhibitor”
Novel Pathway Involving E2F1, ATM and NBS1
$335,975University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA
A Novel Pathway Involving E2F1, ATM and NBS1
$335,975University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Acute Leukemia in the Elderly: Development of Novel, Targeted Therapeutics
$335,948Dan Longo · National Institute On Aging · ZIA · FY2009 · AG
Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer
$335,530Kavitha Yaddanapudi · University Of Louisville · R01 · FY2024 · CA
Re-activating Memory T Cells in the Microenvironment of Human Tumors
$335,421Richard B Bankert · State University Of New York At Buffalo · R01 · FY2011 · CA
Re-activating Memory T Cells in the Microenvironment of Human Tumors
$335,374Richard B Bankert · State University Of New York At Buffalo · R01 · FY2012 · CA
Project 2: Targeting RTK Co-Dependencies in Triple-Negative Breast Cancer
$335,225Thomas Westbrook · Baylor College Of Medicine · P50 · FY2021 · CA
Mechanism of double-negative T cells in antitumor immunity to breast cancer
$335,119Hui Zhang · Washington State University · R01 · FY2024 · CA
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
$335,113Qing Yi · Methodist Hospital Research Institute · R01 · FY2020 · CA
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
$335,113Qing Yi · Methodist Hospital Research Institute · R01 · FY2021 · CA
p53 and checkpoint pathways in cancer cell repliction
$335,062Anindya Dutta · University Of Virginia · R01 · FY2006 · CA
Eukaryotic Nuclear Functions: from Nucleosomes to Chromosomes
$335,000Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · R35 · FY2019 · GM
Eukaryotic Nuclear Functions: from Nucleosomes to Chromosomes
$335,000Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · R35 · FY2022 · GM
Eukaryotic Nuclear Functions: from Nucleosomes to Chromosomes
$335,000Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · R35 · FY2018 · GM
Eukaryotic Nuclear Functions: from Nucleosomes to Chromosomes
$335,000Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · R35 · FY2020 · GM
Project 3: KDM5 Histone Demethylases in Melanoma Growth and Tumor Immunity
$335,000Qin Yan · Yale University · P50 · FY2018 · CA
Project 2- Liquid Biopsies for Melanoma that Metastasizes to Inaccessible Sites
$335,000David A. Hafler · Yale University · P50 · FY2018 · CA
Eukaryotic Nuclear Functions: from Nucleosomes to Chromosomes
$335,000Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · R35 · FY2021 · GM
Platinum-induced lipid reprogramming and tumor immune microenvironment in SCLC
$334,978Lingtao Jin · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Preclinical-Clinical Trials Collaboration to effectively advance new combination therapies for malignant peripheral nerve sheath tumors
$334,967Karen M Cichowski · Brigham And Women'S Hospital · U01 · FY2024 · CA
Project 2: Re-directing the Sensitivity of Metastatic Castration-Resistant Prostate Cancer to Immunotherapy
$334,800Jennifer D Wu · Northwestern University At Chicago · P50 · FY2023 · CA
Project 2: Re-directing the Sensitivity of Metastatic Castration-Resistant Prostate Cancer to Immunotherapy
$334,798Jennifer D Wu · Northwestern University At Chicago · P50 · FY2022 · CA
Phase 2 Irinotecan for Treatment of p53 WT Gastric Adenocarcinoma
$334,719Manish A Shah · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · FD
The MRAD9 Radioresistance Gene
$334,719Howard B Lieberman · Columbia University Health Sciences · R01 · FY2012 · GM
The MRAD9 Radioresistance Gene
$334,719Howard B Lieberman · Columbia University Health Sciences · R01 · FY2011 · GM